OPTIMO

计划入组 53 人

OptiMoM Kindergarten Study

计划入组 158 人 · 首次发布于 2016 年 5 月 3 日

OptiMoM Grows Up: 5.5-year Follow-up of the OptiMoM Fortifier Study

计划入组 149 人 · 首次发布于 2020 年 3 月 16 日

Benzalkonium chloride/octoxynol vaginal gel (Optima)

Otto-von-Guericke-Universität Magdeburg

Germany

Otto Bock Healthcare Products GmbH

Austria

Former Seagen CEO Leads Ottimo Pharma's Novel Cancer Immunotherapy Development

Lotte Biologics Expands Manufacturing Partnership with Ottimo Pharma for Biparatopic Antibody Development

Ottimo Pharma Receives FDA Clearance for First-in-Class Dual PD-1/VEGFR2 Antibody OTP-01